期刊文献+

RF-HPLC测定凝血因子Ⅷ中蔗糖含量方法的建立 被引量:3

下载PDF
导出
摘要 目的测定血液制品人凝血因子Ⅷ中蔗糖的含量。方法利用中性沉淀剂亚铁氰化钾和硫酸锌沉淀样品中蛋白质,采用反相高效液相色谱法,以示差折光检测器检测,用外标法计算含量。结果当蔗糖取样范围为0.5%~2.5%时,直线相关系数为1.000 0,蔗糖的回收率为102%~103%。日内及日间重复测定的相对标准偏差(RSD)分别为0.4%和0.9%,2位操作人员测定结果经T检验P>0.05。结论此方法测定结果稳定、准确,可用于人凝血因子Ⅷ中蔗糖含量的测定。
出处 《中国输血杂志》 CAS CSCD 北大核心 2012年第11期1175-1177,共3页 Chinese Journal of Blood Transfusion
  • 相关文献

参考文献2

二级参考文献14

  • 1刘欣,吴竞生,孙萍,朱薇波,蔡晓燕,郑昌成,王兴兵,杨会志,韩永胜.基因重组人凝血因子Ⅷ在中国人血友病A患者中使用的研究[J].血栓与止血学,2007,13(2):57-59. 被引量:3
  • 2[1]TARANTINO MD,COLLINS PW,et al.Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin-free method:pharmacokinetics,efficacy,and safety in previously treated patients with haemophilia A[J].Haemophilia,2004,10(5):428-437.
  • 3[2]J.SHI,Y.ZHAO,J.WU,et al.Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China[J].Haemophilia,2007,13:351-356.
  • 4[3]ABSHIRE TC,BRACKMANN HH,SCHARRER I et al.Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy-International Kogenate-FS Study Group[J].Thromb Haemost,2000,83:811-816.
  • 5[4]KREUZ W,ESCURIOLA ETTINGSHAUSEN C,FUNK M et al.Prevention of joint damage in hemophilic children with early prophylaxis[J].Orthopade,1999,28:341-346.
  • 6[5]YOSHIOKA A,SHIMA M,FUKUTAKE K,et al.Safety and efficacy of a new recombinant FⅧ formulated with sucrose (rFⅧ-FS) in patients with haemophilia A:a long-term,multicentre clinical study in Japan[J].Haemophilia,2001,7 (3);242-249.
  • 7[6]YOSHIOKA A,FUKUTAKE K,et al.Clinical evaluation of recombinant factor VIII preparation (Kogenate) in previously treated patients with hemophilia A:descriptive meta-analysis of post-marketing study data[J].Int J Hematol,2006,84(2):158-165.
  • 8[8]MEEKS SL,JOSEPHSON CD,et al.Should hemophilia treaters switch to albumin-free recombinant factor VIII concentrates[J].Curr Opin Hematol,2006,13(6):457-461.
  • 9[9]SEREMETIS S,LUSHER JM,ABILDGAARD CF,et al.Human recombinant DNA-derived antihaemophilic factor (factor VIII) in the treatment of haemophilia A:conclusions of a 5-year study of home therapy[J].Haemophilia,1999,5(1):9-16.
  • 10[10]GOUDEMAND J,LAURIAN Y,CALVEZ T,et al.Risk of inhibitors in haemophilia and the type of factor replacement[J].Curr Opin Hematol,2006,13(5):316-322.

共引文献7

同被引文献151

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部